RoukenBio Company Profile, Contacts & Intelligence

Biotechnology ResearchUnited Kingdom95 employeesFounded 2015
2 contacts with email or phone data2 with email data
View verified contacts Compare competitors
Employees
95
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

RoukenBio Overview

RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early discovery, through IND-enabling pivotal data studies, to ‘GMP-ready’ potency assay creation. Working across inflammation, auto-immunity, immuno-oncology and oncology, their team focuses on novel and emerging therapeutic classes including antibodies, cell therapies, nanoparticles, small molecules, protein degraders, peptides, recombinant proteins, vaccines, antibody drug conjugates and more. RoukenBio embraces change and drives innovation with unique services, like the customisable inducible cell line platform, IndEx-2, to stay ahead of the curve. RoukenBio’s assay solutions recreate disease state pathologies as faithfully as possible, and combined with a thought-partner approach to research collaborations, the RoukenBio team uses their scientific empathy to propel their customer’s therapeutic development projects forward.

Headquarters
United Kingdom
Website
antibodyanalytics.com
Industry
Biotechnology Research
Founded
2015
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Bioassays ADCC mAbs ADCs Bi-specifics Biosimilars Immuno-oncology Method development t cell activation t cells tumor microenvironment TDCC

RoukenBio Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.

RoukenBio People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

T
Timothy London
Director of Molecular Biology & Cell Engineering at Roukenbio
L
Liam May
Director at Northedge
K
Kruthika Sundaram, Ph.d.
★Translational Scientist ★Immunologist ★R&D ★Early Stage Drug Discovery ★Assay Designer ★Illustrator
E
A
Andrew Baron
Scientific Director at Rouken Bio
E

RoukenBio Workforce Composition

Seniority breakdown across 4 visible profiles.

Director
3
Individual contributor
1

RoukenBio Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
1
Engineering
1

Compare Similar Companies to RoukenBio

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Merck Life Science Biotechnology Research 8.30K View company
Vertex Pharmaceuticals Biotechnology Research 6.09K View company
RoslinCT Biotechnology Research 431 View company
Cell and Gene Therapy Catapult Biotechnology Research 341 View company
BioAscent Biotechnology Research 92 View company
EnteroBiotix Biotechnology Research 54 View company
Ingenza Ltd Biotechnology Research 51 View company
TC BioPharm Biotechnology Research 44 View company
Roslin Technologies Biotechnology Research 35 View company
NovaBiotics Ltd Biotechnology 14 View company